- Home
- TECH vs LLYVK Comparison
TECH vs LLYVK Comparison
Compare TECH & LLYVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- LLYVK
- Stock Information
- Founded
- TECH 1976
- LLYVK 1991
- Country
- TECH United States
- LLYVK United States
- Employees
- TECH N/A
- LLYVK N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- LLYVK Broadcasting
- Sector
- TECH Health Care
- LLYVK Industrials
- Exchange
- TECH Nasdaq
- LLYVK Nasdaq
- Market Cap
- TECH 8.9B
- LLYVK 7.6B
- IPO Year
- TECH 1989
- LLYVK N/A
- Fundamental
- Price
- TECH $64.75
- LLYVK $79.35
- Analyst Decision
- TECH Strong Buy
- LLYVK
- Analyst Count
- TECH 14
- LLYVK 0
- Target Price
- TECH $71.23
- LLYVK N/A
- AVG Volume (30 Days)
- TECH 2.1M
- LLYVK 323.4K
- Earning Date
- TECH 11-05-2025
- LLYVK 01-01-0001
- Dividend Yield
- TECH 0.50%
- LLYVK N/A
- EPS Growth
- TECH N/A
- LLYVK N/A
- EPS
- TECH 0.49
- LLYVK N/A
- Revenue
- TECH $1,216,732,000.00
- LLYVK N/A
- Revenue This Year
- TECH $3.64
- LLYVK N/A
- Revenue Next Year
- TECH $7.59
- LLYVK $10.89
- P/E Ratio
- TECH $132.78
- LLYVK N/A
- Revenue Growth
- TECH 3.85
- LLYVK N/A
- 52 Week Low
- TECH $46.01
- LLYVK $60.55
- 52 Week High
- TECH $79.28
- LLYVK $102.62
- Technical
- Relative Strength Index (RSI)
- TECH 62.28
- LLYVK 34.92
- Support Level
- TECH $57.02
- LLYVK $78.01
- Resistance Level
- TECH $66.06
- LLYVK $81.74
- Average True Range (ATR)
- TECH 2.06
- LLYVK 2.65
- MACD
- TECH 0.56
- LLYVK -0.36
- Stochastic Oscillator
- TECH 86.04
- LLYVK 22.25
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About LLYVK Liberty Media Corporation
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.